Phase 1b/II study of buparlisib with chemo in squamous NSCLC patients

• Research type

  Research Study

• Full title

  A dose-finding phase Ib study followed by a randomized,double-blind phase II study of carboplatin and paclitaxel with or without buparlisib in patients with previously untreated metastatic non-small cell lung cancer (NSCLC) of squamous histology

• IRAS ID

  134208

• Contact name

  Samreen Ahmed

• Contact email

  samreen.ahmed@uhl-tr.nhs.uk

• Sponsor organisation

  Novartis Pharma Services AG

• Eudract number

  2012-005541-21

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• REC name

  West Midlands - Edgbaston Research Ethics Committee

• REC reference

  13/WM/0301

• Date of REC Opinion

  28 Aug 2013

• REC opinion

  Favourable Opinion